Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MS › Mooreville › NPI 1619298536
NP / PA

Acute Care & Family Clinic of Mooreville

Acute Care & Family Clinic of Mooreville was paid $1.09M by Medicaid between Jan 2018 and Nov 2024, across 23 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 64% of everything it billed.

33Billing provider infoACUTE CARE & FAMILY CLINIC OF MOOREVILLE
MOOREVILLE, MS 38857
33aNPI1619298536assigned 06/15/2010
28Total paid$1.09M
24GClaims43,809
24DCodes billed23
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Family Nurse Practitioner providers in Mississippi

Rank by total paid#6 of 206
Median peer was paid$22K
This provider vs. median50×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20186,438$117K
20194,437$101K
20204,518$94K
20216,971$191K
202210,765$274K
20236,728$200K
2024incomplete3,952$112K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 64% 12,265 10,154 $699K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 7.6% 1,875 1,577 $82K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 6.3% 2,661 2,428 $68K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 6.2% 7,151 6,132 $68K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 4.3% 792 685 $47K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 3.3% 2,537 2,238 $36K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 2.7% 2,882 2,386 $29K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.8% 2,843 2,282 $20K
99051 1.6% 1,747 1,510 $17K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 214 173 $5K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 181 169 $5K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity <1% 28 25 $3K
11 more codes
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 44 $3K
36415 Collection of venous blood by venipuncture <1% 472 $2K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 69 $2K
A4208 Syringe with needle, sterile 3 cc, each <1% 2,960 $2K
87807 <1% 170 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,145 $408.10
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 359 $313.66
81003 <1% 152 $250.11
99000 <1% 127 $22.93
99072 <1% 3,041 $18.05
H0033 Oral medication administration, direct observation <1% 94 $1.60

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialVAIL, ALYSSA (OFFICE MANAGER)